FranΓ§aisπ See the interactive version (live chart) β
For National Healthcare, Corp., we replayed every analyst price target of the past 12 months and measured the real outcome: β% were profitable, average return β (0 calls). At 3 months: β average return (β profitable). The higher the %, the more often analysts were right on this stock.
Their past track record on this stock (targets replayed against real prices) β not a forecast of what will happen.
Not enough scored calls for a reliable ranking.
The analyst consensus on National Healthcare, Corp. (NHC) is "Hold" (0 bullish, 0 bearish calls over 12 months). This is not advice: historically, β% of their targets on this stock turned out profitable over 1 year.
No analyst price target is currently published for National Healthcare, Corp.. However, analysts' historical accuracy on this stock is measured above.
Over 1 year, β% of analyst targets on National Healthcare, Corp. were profitable, for an average return of β (across 0 timestamped calls). This is JPI Invest's accuracy metric.
No analyst price target is available for National Healthcare, Corp.. The most reliable signal is their track record on this stock (β% profitable calls over 1 year) and its past trajectory.
Note: no analyst target is published for this stock, and No reliable 5-10 year price forecast exists (Β« 2030 prediction Β» models are speculative). The most useful inputs: the 12-month median above, these analysts' historical accuracy (β%), and the stock's past trajectory.
Detailed valuation data for National Healthcare, Corp. is available in the interactive analysis.
π See the full interactive analysis of National Healthcare, Corp. β
JPI Invest aggregates analyst recommendations across the entire S&P 500 (plus the S&P MidCap 400), replays them against real prices and measures who predicts best β on results, not reputation. Instead of taking a price target at face value, you see each analyst's track record on each stock.
Explore JPI Invest for free β How it works: the method β
β οΈ Educational information, not investment advice. Analyst price targets are 12-month and can be wrong. Data via Yahoo Finance, recomputed by JPI Invest.